ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kentucky » Rheumatology

Top Rheumatology Prescribers in Kentucky

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RITA EGAN M.D.

Rheumatology

9,921

$1.55M

607
360 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$156
Average prescription price

Avg: $154

GERALD SIMS MD

Rheumatology

7,390

$1.29M

604
389 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

32%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$174
Average prescription price

Avg: $154

MARK HEINICKE M.D.

Rheumatology

7,339

$1.31M

463
287 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

35%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$179
Average prescription price

Avg: $154

HOWARD FEINBERG DO

Rheumatology

7,150

$1.06M

573
371 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$149
Average prescription price

Avg: $154

ARTHUR KUNATH MD

Rheumatology

6,743

$459K

570
412 are 65+

18%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $154

JAYALAKSHMI PAMPATI M.D.

Rheumatology

6,623

$1.23M

394
164 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

39%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$186
Average prescription price

Avg: $154

BILLY BAILEY MD

Rheumatology

5,798

$579K

514
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 11%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$100
Average prescription price

Avg: $154

KELLY COLE M.D.

Rheumatology

5,760

$716K

449
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$124
Average prescription price

Avg: $154

PAUL GOLDFARB M.D.

Rheumatology

5,665

$444K

409
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 11%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 24%

$78
Average prescription price

Avg: $154

LISA JUNE M.D.

Rheumatology

5,654

$1.06M

525
435 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$187
Average prescription price

Avg: $154

MANSOOR AHMED MD

Rheumatology

5,343

$868K

562
305 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$163
Average prescription price

Avg: $154

SYED ABBAS M.D.

Rheumatology

5,205

$1.08M

654
457 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$207
Average prescription price

Avg: $154

ALEXANDER BROWN MD

Rheumatology

4,965

$701K

416
279 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$141
Average prescription price

Avg: $154

TIMOTHY LONESKY D.O.

Rheumatology

4,949

$642K

412
253 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$130
Average prescription price

Avg: $154

CHRISTOPHER PHILLIPS M.D.

Rheumatology

4,823

$550K

496
349 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $154

PAUL SCHNEIDER M.D.

Rheumatology

4,817

$995K

481
405 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$207
Average prescription price

Avg: $154

STEVEN STERN MD

Rheumatology

4,807

$863K

617
471 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$180
Average prescription price

Avg: $154

JEFFREY NEAL M.D.

Rheumatology

4,670

$881K

428
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$189
Average prescription price

Avg: $154

KISHORKUMAR DESAI M.D.

Rheumatology

4,355

$411K

417
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$94
Average prescription price

Avg: $154

MATHEW SAMUEL MD

Rheumatology

4,143

$842K

409
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$203
Average prescription price

Avg: $154

DAVID BREY MD

Rheumatology

4,085

$562K

406
230 are 65+

19%
patients receiving schedule two controlled substances

Avg: 2%

38%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$138
Average prescription price

Avg: $154

NEHA PANSURIA M.D.

Rheumatology

3,909

$551K

482
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$141
Average prescription price

Avg: $154

GARY MARGOLIES M.D.

Rheumatology

3,698

$310K

350
241 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$84
Average prescription price

Avg: $154

GARY CRUMP M.D.

Rheumatology

3,633

$747K

392
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$206
Average prescription price

Avg: $154

WILLIAM BEERS M.D.

Rheumatology

3,583

$449K

342
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$125
Average prescription price

Avg: $154

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank